Skip to content
Health areas

Digestive Health

In a recent study, NORDBIOTIC™ probiotic strains demonstrated a beneficial effect on the physiological functions of the digestive system.

The results of this randomized, double-blind, placebo-controlled trial involving adult participants with diarrhea-predominant irritable bowel syndrome (IBS-D) indicated that supplementation with a product containing NORDBIOTIC™ Lactobacillus, Bifidobacterium, and Streptococcus thermophilus strains positively influenced intestinal comfort compared with placebo. The probiotic was well tolerated and contributed to an improvement in quality of life. These findings suggest that multi-strain probiotics for IBS may provide benefits for adults suffering from IBS-D.

A preparation containing a blend of Bifidobacterium and Lactobacillus strains was shown to improve quality of life, while a synbiotic formulation had a beneficial impact on overall gut health. A systematic review and meta-analysis published in 2020 demonstrated that high-dose single-strain probiotics for IBS, particularly those containing Bifidobacterium or Lactobacillus strains, may improve quality of life in patients.

Therefore, the primary objective of this research project is to evaluate the effects of supplementation with single-strain probiotics containing Bifidobacterium lactis or Bacillus coagulans on the physiological functions of individuals with IBS or SIBO (Small Intestinal Bacterial Overgrowth).

Table 1. Specification of strains (NORDBIOTIC™) used in the evaluated probiotic preparation.

StrainCFU Per CapsuleNumber
Bifidobacterium breve2.08 x 108BB010
Bifidobacterium longum1.39 x 108BL020
Bifidobacterium bifidum1.39 x 108BF030
Bifidobacterium lactis4.17 x 108BL040
Lactobacillus rhamnosus5.56 x 108LR110
Lactobacillus paracasei2.08 x 108LPC100
Lactobacillus acidophilus2.08 x 108LA120
Lactobacillus casei2.08 x 108LC130
Lactobacillus plantarum2. 08 x 108LP140
Streptococcus thermophilus2.08 x 108ST250
Total CFU2.50 x 109 
All the strains are deposited in the patent deposit of the Leibniz Institute DSMZ—German Collection of Microorganisms and Cell Cultures. CFU = colony forming units.

Irritable bowel syndrome (IBS) is one of the most common, yet still not fully understood, gastrointestinal disorders in adults

One suspected etiology involves intestinal dysbiosis, i.e. both quantitative and qualitative alterations in the intestinal microbiota composition, which affect the gut-brain axis. 

The formulation composed of a mixture of Bifidobacterium and Lactobacillus strains reduced the pain severity and improved the quality of life, whereas the synbiotic formulation effectively improved bloating and had a beneficial effect on the general condition of the intestines. A systematic review and meta-analysis published in 2020 showed that high doses of single-strain probiotics for IBS, particularly those containing Bifidobacterium or Lactobacillus strains, may be more effective. Other reports demonstrated a high efficacy of the new-generation probiotic Bacillus coagulans in IBS. Therefore, the main objective of this research project is to assess the efficacy of single-strain probiotics containing Bifidobacterium lactis or Bacillus coagulans in patients with IBS and SIBO. 

Principi N, Cozzali R, Farinelli E, Brusaferro A, Esposito S. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics. J Infect. 2018, 76(2):111-120

FAO/WHO Consultations and Workshops. Safety assessment of foods derived from genetically modified microorganisms. Report of a Joint FAO/WHO Expert Consultation on Foods Derived from Biotechnology, 200, 11–29

Ford, A.C.; Harris, L.A.; Lacy, B.E.; Quigley, E.M.M.; Moayyedi, P. Systematic review with meta-analysis: The efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment. Pharmacol. Ther. 2018, 48: 1044–1060

Skrzydło-Radomańska B., Prozorow-Król B., Cichoż-Lach H., et al. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study. Nutrients 2021,13:756

Skrzydło-Radomańska B., Prozorow-Król B., Cichoż-Lach H., et al. The effectiveness of synbiotic preparation containing Lactobacillus and Bifidobacterium probioticstrains and short chain fructooligosaccharides in patients with diarrhea predominant irritable bowel syndrome-a randomized double-blind, placebo-controlled study. Nutrients 2020, 12:1999

Li  B., Liang L.; Deng, H.; Guo, J.; Shu, H.; Zhang, L. Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-Analysis. Front. Pharmacol. 2020, 11, 332

Gupta AK, Maity C. Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant]. Medicine (Baltimore). 2021, 22;100(3):e23641

NORDBIOTIC™ probiotics for IBS

Subjects of our research in IBS and SIBO:

  • B. lactis NORDBIOTIC™ BI040
  • B coagulans NORDBIOTIC™ BC300
Our studies

NORDBIOTIC™ studies are designed according to the rules of Evidence Based Medicine

3D illustration of a purple immune cell surrounded by smaller cells.

Are you a company?
Learn more about our solutions.
Visit nordicbiotic.com

Close-up of colourful microbial colonies growing on a culture medium.

Powered by NORDBIOTIC™

Discover benefits of scientific grounds for your brand.

Contact us

    I want to receive news

    This website contains information about the research and development activities of Nordic Biotic Sp. z o.o. relating to food products in the form of probiotic preparations. In particular, it is intended to describe and summarize the results of scientific studies organized by the company on such preparations.

    The activities of Nordic Biotic Sp. z o.o.:

    1. Do not relate to medicinal products, including the organization of clinical studies, research and development activities, manufacture, or offering of medicinal products or their components, including active pharmaceutical ingredients.
    2. Do not involve the manufacture or sale of food products to consumers.

    This website is intended exclusively for professional food business operators, in particular manufacturers of food products, including food supplements, who are interested in the research and development activities of Nordic Biotic Sp. z o.o. and in applying the results of such activities in their own manufacturing or distribution operations.